These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31567741)

  • 1. What is the role of triple inhaled therapy in COPD?
    Petite SE
    JAAPA; 2019 Oct; 32(10):44-45. PubMed ID: 31567741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple inhaled therapy for chronic obstructive pulmonary disease.
    Montuschi P; Malerba M; Macis G; Mores N; Santini G
    Drug Discov Today; 2016 Nov; 21(11):1820-1827. PubMed ID: 27452453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual bronchodilation vs triple therapy in the "real-life" COPD DACCORD study.
    Buhl R; Criée CP; Kardos P; Vogelmeier CF; Kostikas K; Lossi NS; Worth H
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2557-2568. PubMed ID: 30197512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GOLD 2017 treatment pathways in 'real life': An analysis of the DACCORD observational study.
    Worth H; Buhl R; Criée CP; Kardos P; Lossi NS; Vogelmeier CF
    Respir Med; 2017 Oct; 131():77-84. PubMed ID: 28947047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of newly diagnosed COPD patients treated with triple inhaled therapy by general practitioners: a real world Italian study.
    Di Marco F; Santus P; Terraneo S; Peruzzi E; Muscianisi E; Ripellino C; Pegoraro V
    NPJ Prim Care Respir Med; 2017 Sep; 27(1):51. PubMed ID: 28883469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple Therapy versus Dual or Monotherapy with Long-Acting Bronchodilators for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis.
    Mammen MJ; Lloyd DR; Kumar S; Ahmed AS; Pai V; Kunadharaju R; Gupta S; Nici L; Aaron SD; Alexander PE
    Ann Am Thorac Soc; 2020 Oct; 17(10):1308-1318. PubMed ID: 32692253
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple Therapy in COPD: What We Know and What We Don't.
    Calverley PMA; Magnussen H; Miravitlles M; Wedzicha JA
    COPD; 2017 Dec; 14(6):648-662. PubMed ID: 29120273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching from long-acting beta-agonist and inhaled corticosteroid to long-acting beta-agonist and long-acting muscarinic antagonist for chronic obstructive pulmonary disease: a case report of inhaled corticosteroid withdrawal.
    Lam JCM
    Intern Med J; 2020 Sep; 50 Suppl 3():15-18. PubMed ID: 32985094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medication management of COPD].
    Gueçamburu M; Zysman M
    Rev Prat; 2024 Jan; 74(1):7-12. PubMed ID: 38329243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple combinations in chronic obstructive pulmonary disease - is three better than two?
    Cazzola M; Matera MG
    Expert Opin Pharmacother; 2014 Dec; 15(17):2475-8. PubMed ID: 25327264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perplexing mortality data from triple therapy trials in COPD.
    Suissa S
    Lancet Respir Med; 2021 Jul; 9(7):684-685. PubMed ID: 34126054
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm.
    Wilkie M; Finch S; Schembri S
    COPD; 2015; 12(5):582-90. PubMed ID: 25774769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Acting β-Agonists (LABA) Combined With Long-Acting Muscarinic Antagonists or LABA Combined With Inhaled Corticosteroids for Patients With Stable COPD.
    Horita N; Nagashima A; Kaneko T
    JAMA; 2017 Oct; 318(13):1274-1275. PubMed ID: 28973232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of use of long-acting bronchodilators in patients with COPD: A nationwide follow-up study of new users in New Zealand.
    Parkin L; Barson D; Zeng J; Horsburgh S; Sharples K; Dummer J
    Respirology; 2018 Jun; 23(6):583-592. PubMed ID: 29265705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Assessment of Disease Burden Prior to Changes in Initial COPD Maintenance Treatment Provide Insight into Remaining Unmet Needs? A Retrospective Database Study in UK Primary Care.
    Landis SH; Wurst K; Le HV; Bonar K; Punekar YS
    COPD; 2017 Feb; 14(1):80-85. PubMed ID: 27819513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.
    Magnussen H; Tetzlaff K; Bateman ED; Watz H; Kirsten AM; Wouters EF; Disse B; Finnigan H; Rodriguez-Roisin R; Calverley PM
    Eur Respir J; 2016 Feb; 47(2):651-4. PubMed ID: 26585433
    [No Abstract]   [Full Text] [Related]  

  • 20. Triple inhaled therapy in COPD patients: determinants of prescription in primary care.
    Vetrano DL; Zucchelli A; Bianchini E; Cricelli C; Piraino A; Zibellini M; Ricci A; Onder G; Lapi F
    Respir Med; 2019; 154():12-17. PubMed ID: 31202120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.